Intestinal treatment

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/22 (2006.01) A61P 1/00 (2006.01) A61P 1/12 (2006.01)

Patent

CA 2737828

Y4 receptor agonists which are selective of the Y4 receptor over the Y1 and Y2 receptors, are useful in the prevention and/or treatment of damage to bowel function caused by radiation therapy, radiation exposure, cytotoxic chemotherapy, inflammation or ischemia-reperfusion of intestinal mucosa.

Des agonistes de récepteur Y4, qui sont sélectifs pour le récepteur Y4 de préférence aux récepteurs Y1 et Y2, sont utiles dans la prévention et/ou le traitement d'altérations de la fonction intestinale provoquées par une radiothérapie, une exposition à un rayonnement, une chimiothérapie cytotoxique, une inflammation ou une ischémie-reperfusion de la muqueuse intestinale.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Intestinal treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intestinal treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intestinal treatment will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1978573

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.